Small Molecule Drug Discovery

Global Market Trajectory & Analytics

MCP14780

EXECUTIVE ENGAGEMENTS

POOL

5443
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

871
Interactions with Platform & by Email

PARTICIPANTS

163
Unique # Participated

VALIDATIONS

33
Responses Validated*

COMPANIES

21
Responses Validated*
* Login for a full stack data experience

DATE

JAN 2022

TABLES

123

PAGES

184

EDITION

9

PRICE

USD 4950

CODE

MCP14780


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

S M N T

%

VALIDATED RESEARCH *

S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T

* S = Strong; M = Moderate; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Small Molecule Drug Discovery estimated at US$30.1 Billion in the year 2020, is projected to reach a revised size of US$43.7 Billion by 2027, growing at a CAGR of 5.5% over the analysis period 2020-2027. Oncology, one of the segments analyzed in the report, is projected to record a 6.7% CAGR and reach US$18.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Central Nervous System segment is readjusted to a revised 6% CAGR for the next 7-year period.
The Small Molecule Drug Discovery market in the U.S. is estimated at US$8.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$7.6 Billion by the year 2027 trailing a CAGR of 5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.3% and 4.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.
In the global Cardiovascular segment, USA, Canada, Japan, China and Europe will drive the 5.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$917.5 Million in the year 2020 will reach a projected size of US$1.3 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$5 Billion by the year 2027.

SELECT PLAYERS

AstraZeneca PLC; Boehringer Ingelheim International GmbH; Bristol-Myers Squibb Company; Gilead Sciences, Inc.; GlaxoSmithKline PLC; Johnson & Johnson; Merck & Co., Inc.; Pfizer, Inc.; Teva Pharmaceutical Industries Ltd.

SEGMENTS

» Process Phase (Target Id/Validation, Hit Generation and Selection, Lead Identification, Lead Optimization) » Therapeutic Area (Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological, Other Therapeutic Areas)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Small Molecule Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Small Molecule Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Small Molecule Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Central Nervous System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Central Nervous System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Central Nervous System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Anti-Infective by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Anti-Infective by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Anti-Infective by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Immunological by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Immunological by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Immunological by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Therapeutic Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Target Id/Validation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Target Id/Validation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Target Id/Validation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Hit Generation and Selection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Hit Generation and Selection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Hit Generation and Selection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Lead Identification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Lead Identification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Lead Identification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Lead Optimization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Lead Optimization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Lead Optimization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Small Molecule Drug Discovery by Therapeutic Area - Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Small Molecule Drug Discovery by Therapeutic Area - Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Small Molecule Drug Discovery by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Small Molecule Drug Discovery by Process Phase - Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Small Molecule Drug Discovery by Process Phase - Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Small Molecule Drug Discovery by Process Phase - Percentage Breakdown of Value Sales for Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for Small Molecule Drug Discovery by Therapeutic Area - Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Small Molecule Drug Discovery by Therapeutic Area - Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Small Molecule Drug Discovery by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Small Molecule Drug Discovery by Process Phase - Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Small Molecule Drug Discovery by Process Phase - Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Small Molecule Drug Discovery by Process Phase - Percentage Breakdown of Value Sales for Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for Small Molecule Drug Discovery by Therapeutic Area - Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Small Molecule Drug Discovery by Therapeutic Area - Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Small Molecule Drug Discovery by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Small Molecule Drug Discovery by Process Phase - Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Small Molecule Drug Discovery by Process Phase - Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Small Molecule Drug Discovery by Process Phase - Percentage Breakdown of Value Sales for Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for Small Molecule Drug Discovery by Therapeutic Area - Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Small Molecule Drug Discovery by Therapeutic Area - Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Small Molecule Drug Discovery by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas for the Years 2012, 2020 & 2027
China Current & Future Analysis for Small Molecule Drug Discovery by Process Phase - Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Small Molecule Drug Discovery by Process Phase - Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Small Molecule Drug Discovery by Process Phase - Percentage Breakdown of Value Sales for Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for Small Molecule Drug Discovery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe Historic Review for Small Molecule Drug Discovery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Small Molecule Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Small Molecule Drug Discovery by Therapeutic Area - Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Small Molecule Drug Discovery by Therapeutic Area - Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Small Molecule Drug Discovery by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Small Molecule Drug Discovery by Process Phase - Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Small Molecule Drug Discovery by Process Phase - Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Small Molecule Drug Discovery by Process Phase - Percentage Breakdown of Value Sales for Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Small Molecule Drug Discovery by Therapeutic Area - Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Small Molecule Drug Discovery by Therapeutic Area - Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Small Molecule Drug Discovery by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas for the Years 2012, 2020 & 2027
France Current & Future Analysis for Small Molecule Drug Discovery by Process Phase - Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Small Molecule Drug Discovery by Process Phase - Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Small Molecule Drug Discovery by Process Phase - Percentage Breakdown of Value Sales for Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Small Molecule Drug Discovery by Therapeutic Area - Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Small Molecule Drug Discovery by Therapeutic Area - Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Small Molecule Drug Discovery by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Small Molecule Drug Discovery by Process Phase - Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Small Molecule Drug Discovery by Process Phase - Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Small Molecule Drug Discovery by Process Phase - Percentage Breakdown of Value Sales for Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for Small Molecule Drug Discovery by Therapeutic Area - Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Small Molecule Drug Discovery by Therapeutic Area - Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Small Molecule Drug Discovery by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Small Molecule Drug Discovery by Process Phase - Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Small Molecule Drug Discovery by Process Phase - Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Small Molecule Drug Discovery by Process Phase - Percentage Breakdown of Value Sales for Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Small Molecule Drug Discovery by Therapeutic Area - Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Small Molecule Drug Discovery by Therapeutic Area - Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Small Molecule Drug Discovery by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Small Molecule Drug Discovery by Process Phase - Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Small Molecule Drug Discovery by Process Phase - Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Small Molecule Drug Discovery by Process Phase - Percentage Breakdown of Value Sales for Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Small Molecule Drug Discovery by Therapeutic Area - Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Small Molecule Drug Discovery by Therapeutic Area - Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Small Molecule Drug Discovery by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Small Molecule Drug Discovery by Process Phase - Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Small Molecule Drug Discovery by Process Phase - Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Small Molecule Drug Discovery by Process Phase - Percentage Breakdown of Value Sales for Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Small Molecule Drug Discovery by Therapeutic Area - Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Small Molecule Drug Discovery by Therapeutic Area - Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Small Molecule Drug Discovery by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Small Molecule Drug Discovery by Process Phase - Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Small Molecule Drug Discovery by Process Phase - Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Small Molecule Drug Discovery by Process Phase - Percentage Breakdown of Value Sales for Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization for the Years 2012, 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Small Molecule Drug Discovery by Therapeutic Area - Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Small Molecule Drug Discovery by Therapeutic Area - Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Small Molecule Drug Discovery by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Central Nervous System, Cardiovascular, Anti-Infective, Immunological and Other Therapeutic Areas for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for Small Molecule Drug Discovery by Process Phase - Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Small Molecule Drug Discovery by Process Phase - Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Small Molecule Drug Discovery by Process Phase - Percentage Breakdown of Value Sales for Target Id/Validation, Hit Generation and Selection, Lead Identification and Lead Optimization for the Years 2012, 2020 & 2027
Total Companies Profiled: 21

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com